82 related articles for article (PubMed ID: 8340059)
1. Serum levels of transforming growth factor-alpha in patients after partial hepatectomy as determined with an enzyme-linked immunosorbent assay.
Tomiya T; Fujiwara K
Hepatology; 1993 Aug; 18(2):304-8. PubMed ID: 8340059
[TBL] [Abstract][Full Text] [Related]
2. Serum transforming growth factor-alpha level can be a parameter for evaluating liver regeneration after partial hepatectomy in patients with liver cancer.
Tomiya T; Hayashi S; Yanase M; Umeda N; Tani M; Yamada S; Masaki N; Ogata I; Fujiwara K
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-14-S6-17. PubMed ID: 9151911
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting liver regeneration after right portal vein embolization.
Kusaka K; Imamura H; Tomiya T; Makuuchi M
Hepatogastroenterology; 2004; 51(56):532-5. PubMed ID: 15086196
[TBL] [Abstract][Full Text] [Related]
4. Changes in serum levels of growth factors in healthy individuals after living related liver donation.
Efimova EA; Glanemann M; Nussler AK; Schumacher G; Settmacher U; Jonas S; Nussler N; Neuhaus P
Transplant Proc; 2005 Mar; 37(2):1074-5. PubMed ID: 15848626
[TBL] [Abstract][Full Text] [Related]
5. Plasma heparin-binding EGF-like growth factor levels in patients after partial hepatectomy as determined with an enzyme-linked immunosorbent assay.
Yamada A; Kawata S; Tamura S; Kiso S; Higashiyama S; Umeshita K; Sakon M; Taniguchi N; Monden M; Matsuzawa Y
Biochem Biophys Res Commun; 1998 May; 246(3):783-7. PubMed ID: 9618289
[TBL] [Abstract][Full Text] [Related]
6. Liver regeneration in fulminant hepatitis as evaluated by serum transforming growth factor alpha levels.
Tomiya T; Fujiwara K
Hepatology; 1996 Feb; 23(2):253-7. PubMed ID: 8591849
[TBL] [Abstract][Full Text] [Related]
7. Portal serum human hepatocyte growth factor levels after partial hepatectomy.
Higaki I; Yamazaki O; Matsuyama M; Horii K; Kawai S; Hirohashi K; Kinoshita H
Hepatogastroenterology; 1999; 46(26):1078-82. PubMed ID: 10370670
[TBL] [Abstract][Full Text] [Related]
8. Changes in serum human hepatocyte growth factor levels after transcatheter arterial embolization and partial hepatectomy.
Kaneko A; Hayashi N; Tanaka Y; Ito T; Kasahara A; Kubo M; Mukuda T; Fusamoto H; Kamada T
Am J Gastroenterol; 1992 Aug; 87(8):1014-7. PubMed ID: 1322635
[TBL] [Abstract][Full Text] [Related]
9. The clinical value of hepatocyte growth factor and its receptor--c-met for liver cancer patients with hepatectomy.
Wu F; Wu L; Zheng S; Ding W; Teng L; Wang Z; Ma Z; Zhao W
Dig Liver Dis; 2006 Jul; 38(7):490-7. PubMed ID: 16627020
[TBL] [Abstract][Full Text] [Related]
10. Detection of serum transforming growth factor-alpha in patients of primary epithelial ovarian cancers by enzyme immunoassay.
Chien CH; Huang CC; Lin YH; Shen J; Chow SN
Gynecol Oncol; 1997 Sep; 66(3):405-10. PubMed ID: 9299253
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-9 is an important factor in hepatic regeneration after partial hepatectomy in mice.
Olle EW; Ren X; McClintock SD; Warner RL; Deogracias MP; Johnson KJ; Colletti LM
Hepatology; 2006 Sep; 44(3):540-9. PubMed ID: 16941692
[TBL] [Abstract][Full Text] [Related]
12. Serum interleukin-6 and hepatocyte growth factor levels in patients after hepatectomy.
Chijiiwa K; Saiki S; Tanaka M
Hepatogastroenterology; 2002; 49(44):467-71. PubMed ID: 11995475
[TBL] [Abstract][Full Text] [Related]
13. High serum levels of vascular endothelial growth factor after hepatectomy are associated with poor prognosis in hepatocellular carcinoma.
Tamesa T; Iizuka N; Mori N; Okada T; Takemoto N; Tangoku A; Oka M
Hepatogastroenterology; 2009; 56(93):1122-6. PubMed ID: 19760954
[TBL] [Abstract][Full Text] [Related]
14. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor and transforming growth factor beta1 contribute to regeneration of small-for-size liver graft immediately after transplantation.
Ninomiya M; Harada N; Shiotani S; Hiroshige S; Minagawa R; Soejima Y; Suehiro T; Nishizaki T; Shimada M; Sugimachi K
Transpl Int; 2003 Nov; 16(11):814-9. PubMed ID: 12879228
[TBL] [Abstract][Full Text] [Related]
16. Serum hepatocyte growth factor before and after resection for hepatocellular carcinoma.
Hu RH; Lee PH; Yu SC; Sheu JC; Lai MY
Hepatogastroenterology; 1999; 46(27):1842-7. PubMed ID: 10430357
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
[TBL] [Abstract][Full Text] [Related]
18. Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay.
Tsubouchi H; Niitani Y; Hirono S; Nakayama H; Gohda E; Arakaki N; Sakiyama O; Takahashi K; Kimoto M; Kawakami S
Hepatology; 1991 Jan; 13(1):1-5. PubMed ID: 1824837
[TBL] [Abstract][Full Text] [Related]
19. Normal liver regeneration and liver cell apoptosis after partial hepatectomy in tumor necrosis factor-alpha-deficient mice.
Hayashi H; Nagaki M; Imose M; Osawa Y; Kimura K; Takai S; Imao M; Naiki T; Kato T; Moriwaki H
Liver Int; 2005 Feb; 25(1):162-70. PubMed ID: 15698414
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 6 in bile as an indicator of liver function after hepatectomy in patients with biliary tract carcinoma.
Maeda A; Nagino M; Takeuchi E; Sano T; Kurumiya Y; Nimura Y
Br J Surg; 1999 Apr; 86(4):458-64. PubMed ID: 10215814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
